©2026 Bryn Mawr Communications, LLC.
All Rights Reserved

Terms and Conditions • Privacy Policy

Contributor:

Matching Patients to Therapy in Wet AMD: Lifestyle Factors That Guide Treatment

COVID-19: Are Today's Protocols Tomorrow's Routines?

COVID-19: Are Today's Protocols Tomorrow's Routines?

John Kitchens, MD; Murtaza "Moo" Adam, MD; David R.P. Almeida, MD, PhD, MBA; and Christina Weng, MD, MBA

A Hybrid Vitrectomy
A Hybrid Vitrectomy

Murtaza Adam, MD

A Challenging IOL Dislocation
A Challenging IOL Dislocation

Murtaza Adam, MD, Royce Chen, MD

Talking to Patients About Treatment Risks
Talking to Patients About Treatment Risks

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

Why Retina Specialists Are Growing More Comfortable With Early Treatment
Why Retina Specialists Are Growing More Comfortable With Early Treatment

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

Delayed Complement Inhibition Therapy per Patient Request
Delayed Complement Inhibition Therapy per Patient Request

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

Multimodal Imaging for Biomarker Detection in GA Patients
Multimodal Imaging for Biomarker Detection in GA Patients

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

GA in the Presence of Dense Cataract, Followed by CNV Development
GA in the Presence of Dense Cataract, Followed by CNV Development

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

The Neverending Learning Curve
The Neverending Learning Curve

Murtaza Adam, MD

Complement Inhibition Therapy in a Monocular Patient With a New CNV
Complement Inhibition Therapy in a Monocular Patient With a New CNV

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

GA Patient Who Becomes Monocular Over Time Due to the Wet AMD
GA Patient Who Becomes Monocular Over Time Due to the Wet AMD

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

COVID-19: Are Today's Protocols Tomorrow's Routines?
COVID-19: Are Today's Protocols Tomorrow's Routines?

Christina Weng, MD, MBA, David R.P. Almeida, MD, PhD, MBA, John W. Kitchens, MD, Murtaza “Moo” Adam, MD

Biomarkers, Imaging, and Early Treatment Decisions in Geographic Atrophy

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

Evolving Practice Patterns and Dosing Strategies in Geographic Atrophy

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

Barriers to Care, Patient Education, and Treatment Decisions in Geographic Atrophy

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

Matching Patients to Therapy in Wet AMD: Lifestyle Factors That Guide Treatment

John Kitchens, MD; Murtaza Adam, MD; and Aleksandra Rachitskaya, MD

ARVO '26: DME Delphi Study and RHONE-X

Baruch Kuppermann, MD, PhD; and Murtaza Adam, MD